Tracing the Evolution of Prostate Brachytherapy in the 20th Century.

Brachytherapy History Prostate cancer Radium

Journal

Oncology
ISSN: 1423-0232
Titre abrégé: Oncology
Pays: Switzerland
ID NLM: 0135054

Informations de publication

Date de publication:
06 Oct 2023
Historique:
received: 03 08 2023
accepted: 31 08 2023
medline: 9 10 2023
pubmed: 9 10 2023
entrez: 8 10 2023
Statut: aheadofprint

Résumé

Prostate brachytherapy (BT) techniques have evolved over the past century. This paper aimed to preserve our collective memory of history and the early development of its technique. We searched articles in PubMed and Google Scholar using keywords referring to authors, dates, and BT technical details, including different radioactive sources and country-specific publications. We reviewed the work published by Holm and Aronowitz. The digital library Internet Archives was used to retrieve original journal articles, science newspaper printings, and government reports, which allowed us to situate the development of BT in its sociopolitical context in Europe and the USA. Our search was conducted in English, French, and German languages. Early BT methods were developed by European physicians with early access to radium. Technical advancements were made by HH Young, who brought this practice to the USA, where Barringer pioneered the use of radon seeds and low-dose interstitial brachytherapy. While centralized radiotherapy centers, such as Memorial Hospital in New York, emerged for training and research, the high cost of radium and opposing interests made brachytherapy harder to implement in Germany. After World War II, the introduction of man-made radioisotopes allowed experiments with colloidal solutions and new seeds, including I-125. In the 1980s, transrectal ultrasound allowed for more accurate radioactive seed insertion and replaced the transrectal finger guidance.

Sections du résumé

BACKGROUND BACKGROUND
Prostate brachytherapy (BT) techniques have evolved over the past century. This paper aimed to preserve our collective memory of history and the early development of its technique. We searched articles in PubMed and Google Scholar using keywords referring to authors, dates, and BT technical details, including different radioactive sources and country-specific publications. We reviewed the work published by Holm and Aronowitz. The digital library Internet Archives was used to retrieve original journal articles, science newspaper printings, and government reports, which allowed us to situate the development of BT in its sociopolitical context in Europe and the USA. Our search was conducted in English, French, and German languages.
SUMMARY CONCLUSIONS
Early BT methods were developed by European physicians with early access to radium. Technical advancements were made by HH Young, who brought this practice to the USA, where Barringer pioneered the use of radon seeds and low-dose interstitial brachytherapy. While centralized radiotherapy centers, such as Memorial Hospital in New York, emerged for training and research, the high cost of radium and opposing interests made brachytherapy harder to implement in Germany. After World War II, the introduction of man-made radioisotopes allowed experiments with colloidal solutions and new seeds, including I-125. In the 1980s, transrectal ultrasound allowed for more accurate radioactive seed insertion and replaced the transrectal finger guidance.

Identifiants

pubmed: 37806307
pii: 000534017
doi: 10.1159/000534017
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-8

Informations de copyright

© 2023 S. Karger AG, Basel.

Auteurs

Michael S Schaulin (MS)

Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal, Montreal, Québec, Canada.

Guila Delouya (G)

Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal, Montreal, Québec, Canada.

Daniel Zwahlen (D)

Department of Radiation Oncology, Kantonsspital Winterthur, Winterthur, Switzerland.

Daniel Taussky (D)

Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal, Montreal, Québec, Canada.

Classifications MeSH